跳至主要内容
临床试验/EUCTR2007-000030-39-NL
EUCTR2007-000030-39-NL进行中(未招募)不适用

Prazosin as add-on therapy in the pharmacological treatment of sleep disturbances in post traumatic stress disorder, a placebo-controlled study using polysomnography - prazosin in the treatment of PTSD related sleep disturbances

Ministery of Defense, Military Mental Health - Research Centre0 个研究点目标入组 30 人开始时间: 2007年8月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • -Age between 18 - 65
  • -Veterans or active military personnel
  • -History of deployment
  • -Subjects have to meet DSM-IV criteria for PTSD, as measured by SCID, with a CAPS score of > 50
  • -PSQI scores of > 10
  • -SSRI treatment for at least 6 weeks at stable and adequate dosage
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Substance or alcohol abuse/ dependence within the past six months
  • -Major systemic or neurological diseases
  • -Organic sleep disorders (sleep apnea syndrome, periodic limb movement disorder, narcolepsy)
  • -Orthostatic hypotension before treatment, defined as a fall in systolic blood pressure of more then 20mmHg, or a fall in diastolic blood pressure of more then 10 mmHg after 2 minutes standing.
  • -Use of psychotropic medication, other than a SSRI, or hypertensive agents.
  • -Chronic benzodiazepine use. Benzodiazepine use on demand has to be stopped at least two weeks before the study. A patient will only be included if no rebound insomnia has been noticed prior to the study.

研究者

发起方
Ministery of Defense, Military Mental Health - Research Centre

相似试验